One of the primary mechanisms underlying platinum resistance involves the upregulation of DNA damage repair pathways, including key mediators such as CHEK1, MLH1, MSH2, RAD51, and PMS2, which enable tumor cells to withstand platinum-induced cytotoxicity [60,61]. The gene discussed is RAD51; the disease is neoplasm.